UK
[ Ссылка ]

[ Ссылка ]

Cases, + 2,357 + 2,474 = 4,439,691

Deaths, + 4 + 20 = 127,629

Deaths, + 290 (7 days) = 151,533

Vaccinations

[ Ссылка ]

First dose, + 115,053 = 35,587,348 (67.6%)

Second dose, + 231,835 = 18,088,385 (34.3%)

France

[ Ссылка ]

India variant, 20 cases, 5 clusters

Olivier Veran, Health Minister

Reopen bars and restaurants for outdoor service on May 19

Vaccinations

One dose, 17.8 million (26.6%)

Second dose, 7.8 million

ITU cases

Saturday, 5,005

Sunday, 4,971

First drop below, 5,000 since March 29

US

[ Ссылка ]

[ Ссылка ]

U.S. Food and Drug Administration

Expanded emergency use authorization

Pfizer-BioNTech COVID-19 Vaccine

12 to 15 years of age

Janet Woodcock, (FDA)

allows for a younger population to be protected

bringing us closer to returning to a sense of normalcy

and to ending the pandemic

March 1, 2020 through April 30, 2021

1.5 million COVID-19 cases in individuals 11 to 17 years

Two doses, three weeks apart

Potential benefits of this vaccine in individuals 12 years of age and older outweigh the known and potential risks




Scientific Brief: SARS-CoV-2 Transmission (7th May)

[ Ссылка ]

[ Ссылка ]

SARS-CoV-2 is transmitted by exposure to infectious respiratory fluids

People release respiratory fluids

Infection depends on concentration of viral particles

Three principal ways:

Inhalation

Mucous membranes depositions

Touching mucous membranes

Factors in inoculum

Airstream

Thermal layering and

Initial jetting of exhalations

Enclosed spaces

Increased exhalation

Prolonged exposure

Progressive loss of viral viability and infectiousness

Temperature

Humidity

Ultraviolet radiation

Infection still possible

More than 6 feet away

Passing through a space an infectious person has left

Prevention of transmission

Physical distancing

Well-fitting masks

Adequate ventilation

Avoidance of crowded indoor spaces

[ Ссылка ]00869-2/fulltext


[ Ссылка ]

History

CDC, masks, 19th April 2020

[ Ссылка ]

WHO, masks, 5th June 2020

[ Ссылка ]

[ Ссылка ]

Vaccine factors

[ Ссылка ]

AstraZeneca, 20 manufacturing partners around the world

With which it has shared the Covid-19 vaccine technology

India’s Serum Institute, has supplied 300m doses so far to 165 countries

90% of India’s vaccines so far

Providing 98% of the supply to Covax

Pledged not-for-profit basis for the duration

AstraZeneca lost money first three months of the year

Pfizer and Moderna are on course to make $45bn (£32bn) collectively from their coronavirus vaccines this year

свернуть